Romo-Gamboa JP, Sandoval-Pérez BA, Rodríguez-López AB, Torres-González MA, Barrera-de León JC

Language: Spanish
References: 17
Page: 72-79
PDF size: 314.07 Kb.

ABSTRACT

Background: Ventilator-associated pneumonia (VAP) represents the second cause of nosocomial infections and it is associated with greater morbility, duration of mechanical ventilation (MV), and hospital stay. The objective was to determine factors related with VAP in neonates.
Methods: Analytical transversal study including newborns admitted already intubated with at least 48 hours of MV or who were intubated in Neonatal Therapy. VAP was defined according to the criteria of the Centers for Disease Control and Prevention: “those patients submitted to MV during at least 48 hours”. We used inferential statistics for statistical analysis (chi squared, Mann-Whitney U test, and Kaplan-Meier estimator).
Results: 82 neonates were studied, out of which 27 developed VAP (33%). The median time to develop pneumonia was 6 days (range 5-11). The most commonly isolated germ was Escherichia coli (27%). Statistically significant variables were gestational age (p = 0.05), and the use of antacids at admission (p = 0.007). Patients with pneumonia had longer hospital stay (p = 0.001) and time with MV (p = 0.002). Of all the patients, 22 neonates died (27%), of which nine patients had VAP.
Conclusion: Risk factors for VAP in neonates include lower gestational age, the use of antacids, and prolonged MV.

REFERENCES

1. Centers for Disease Control and Prevention. Criteria for defining nosocomial pneumonia. Atlanta, Georgia: CDC; 2005. Disponible en http:// es.halyardhealth.com/media/1633/cdc-guidelinesfor- defining-nosocomial-pneumonia-criteria-v1.pdf

2. Vento M, Cheung PY, Aguar M. The first golden minutes of the extremely-low-gestational-age neonate: a gentle approach. Neonatology. 2009;95:286-98.

3. Morris AC, Kefala K, Simpson AJ, Wilkinson TS, Everingham K, Kerslake D, et al. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax. 2009;64(6):516-22.

4. Cernada M, Aguar M, Brugada M, Gutiérrez A, López JL, Castell M, et al. Ventilator-associated pneumonia in newborn infants diagnosed with an invasive bronchoalveolar lavage technique: a prospective observational study. Pediatr Crit Care Med. 2013 Jan;14(1):55-61.

5. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ. Ventilator- associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics. 2003 Dec;112(6 Pt 1):1283-9.

6. Afjeh SA, Sabzehei MK, Karimi A, Shiva F, Shamshiri AR. Surveillance of ventilator associated pneumonia in a neonatal intensive care unit: characteristics, risk factors, and outcome. Arch Iran Med. 2012; 15:567-71.

7. Yuan TM, Chen LH, Yu HM. Risk factors and outcomes for ventilator-associated pneumonia in neonatal intensive care unit patients. J Perinat Med. 2007;35:334-8.

8. Aly H, Badawy M, El-Kholy A, Nabil R, Mohamed A. Randomized controlled trial on tracheal colonization of ventilated infants: Can gravity prevent ventilator associated pneumonia? Pediatrics. 2008;122(4): 770-4.

9. Tripathi S, Malik GK, Jain A, Kohli N. Study of ventilator associated pneumonia in Neonatal Intensive Care Unit: Characteristics, risk factors and outcome. Internet J Med Uptodate. 2010;5(1):12-9.

10. National Nosocomial Infections Surveillance System: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470-85.

11. Geffers C, Baerwolff S, Schwab F, Gastmeier P. Incidence of healthcare-associated infections in highrisk neonates: results from the German surveillance system for very-low-birthweight infants. J Hosp Infect. 2008;68:214-21.

12. Stover BH, Shulman ST, Bratcher DF, Brady MT, Levine GL, Jarvis WR. Nosocomial infection rates in the US children’s hospitals, neonatal and pediatric intensive care units. Am Infect Control J. 2001;29:152-7.

13. Memish ZA, Cunningham G, Oni GA, Djazmati W. The incidence and risk factors of ventilator associated pneumonia in Riyadh Hospital. Infect Control Hosp Epidemiol. 2000 Apr;21(4):271-3.

14. Yildizdas D, Yapicioglu H, Yilmaz HL. Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole. J Crit Care. 2002 Dec;17(4):240-5.

15. Won SP, Chou HC, Hsieh WS, Chen CY, Huang SM, Tsou KI, et al. Hand-washing program for the prevention of nosocomial infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2004;25:742-6.

16. Raymond J, Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study – European Study Group. Infect Control Hosp Epidemiol. 2000;21:260-3.

17. Gautam A, Ganu SS, Tegg OJ, et al: Ventilator-associated pneumonia in a tertiary paediatric intensive care unit: a 1-year prospective observational study. Crit Care Resusc. 2012;14:283-9.